Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, May 05, 2016 ) The report provides comprehensive information on the therapeutics under development for Emergent BioSolutions Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Emergent BioSolutions Inc. and features dormant and discontinued projects.
Publisher's Emergent BioSolutions Inc Industry report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Other Key Points in Report:
- The report provides a snapshot of the global therapeutic landscape of Emergent BioSolutions Inc. - The report reviews pipeline therapeutics for Emergent BioSolutions Inc. by companies and universities/research institutes based on information derived from company and industry-specific sources - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved Emergent BioSolutions Inc. therapeutics and enlists all their major and minor projects - The report assesses Emergent BioSolutions Inc. therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
Inquire before Purchasing Report @ http://www.reportsweb.com/inquiry&RW0001231638/buying
Reasons to Buy
Evaluate Allergan Plc's strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Allergan Plc - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Allergan Plc's pipeline depth and focus of pipeline therapeutics
Ask for Sample Report @ http://www.reportsweb.com/inquiry&RW0001231638/sample
Table of Content: An Overview
Emergent BioSolutions Inc. Snapshot 6 Emergent BioSolutions Inc. Overview 6 Key Information 6 Key Facts 6 Emergent BioSolutions Inc. - Research and Development Overview 7 Key Therapeutic Areas 7 Emergent BioSolutions Inc. - Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products - Monotherapy 11 Pipeline Products - Partnered Products 12 Partnered Products/Combination Treatment Modalities 13 Emergent BioSolutions Inc. - Pipeline Products Glance 14 Emergent BioSolutions Inc. - Late Stage Pipeline Products 14 Filing rejected/Withdrawn Products/Combination Treatment Modalities 14
Ask for Discount on Report @ http://www.reportsweb.com/inquiry&RW0001231638/discount
Emergent BioSolutions Inc. - Clinical Stage Pipeline Products 15 Phase II Products/Combination Treatment Modalities 15 Phase I Products/Combination Treatment Modalities 16 Emergent BioSolutions Inc. - Early Stage Pipeline Products 17 Preclinical Products/Combination Treatment Modalities 17 Discovery Products/Combination Treatment Modalities 18 Emergent BioSolutions Inc. - Drug Profiles 19 coagulation factor IX (recombinant) 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 AV-7909 21 Product Description 21 Mechanism of Action 21
Purchase Complete Report @ http://www.reportsweb.com/buy&RW0001231638/buy/1500
About ReportsWeb: ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Contact Us: Email: sales@reportsweb.com Call: +1-646-491-9876
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|